Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point

N Arber - Cancer Epidemiology Biomarkers & Prevention, 2008 - AACR
The limited success of current treatments for most advanced common malignancies
highlights the importance of cancer prevention. Clinical trials on cyclooxygenase (COX) …

KINK-1, a novel small-molecule inhibitor of IKKβ, and the susceptibility of melanoma cells to antitumoral treatment

M Schön, BG Wienrich, S Kneitz… - Journal of the …, 2008 - academic.oup.com
Background Increasing the efficacy of chemotherapeutics by reducing chemoresistance may
be a useful strategy in cancer therapy. Constitutive activation of nuclear factor-kappa B (NF …

The potential of resveratrol against human gliomas

N Gagliano, G Aldini, G Colombo, R Rossi… - Anti-cancer …, 2010 - journals.lww.com
There is growing interest in dietary phytochemicals as potential cancer chemopreventive
agents. Resveratrol (3, 4′, 5-trihydroxy-trans-stilbene), a naturally occurring phytoalexin …

Obesity-driven inflammation and colorectal cancer

N Vazzana, S Riondino, V Toto… - Current medicinal …, 2012 - ingentaconnect.com
Visceral obesity is characterized by increased risk of cardiovascular disease as well as
higher incidence of malignancies, including colorectal cancer (CRC), although the …

Preventive effects of etodolac, a selective cyclooxygenase‐2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori‐negative …

K Yanaoka, M Oka, N Yoshimura… - … journal of cancer, 2010 - Wiley Online Library
The present study investigated the preventive effects of etodolac, a selective cyclo‐
oxygenase (COX)‐2 inhibitor, on metachronous cancer development after endoscopic …

Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues

G Wang, X Wang, S Wang, H Song, H Sun… - International journal of …, 2008 - Springer
Background and aims Early detection and treatment of human colorectal cancers remain a
challenge. Identification of new potential markers may help in the diagnosis of colorectal …

Aspirin and the prevention of colorectal cancer

A Ferrandez, E Piazuelo, A Castells - Best practice & research Clinical …, 2012 - Elsevier
A large body of evidence from basic science, epidemiologic observations and population-
based studies demonstrates that aspirin, as well as other non-steroidal anti-inflammatory …

Consensus on the prevention, screening, early diagnosis and treatment of colorectal tumors in China: Chinese Society of Gastroenterology, October 14-15, 2011 …

JY Fang, S Zheng, B Jiang, MD Lai, DC Fang… - Gastrointestinal …, 2014 - karger.com
Background: Colorectal cancer (CRC) is steadily increasing in China. Colorectal adenoma
(CRA) is the most important precancerous disease of CRC. Screening for colorectal tumors …

Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and …

G Daneau, R Boidot, P Martinive, O Feron - Clinical Cancer Research, 2010 - AACR
Purpose: Cyclic hypoxia in tumors originates from heterogeneities in RBC flux and
influences not only tumor cells but also endothelial cells lining tumor blood vessels. Whether …

Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA

EJ Carrier, I Zagol-Ikapitte, V Amarnath, O Boutaud… - Biochemistry, 2014 - ACS Publications
Inflammation and subsequent cyclooxygenase-2 (COX-2) activity has long been linked with
the development of cancer, although little is known about any epigenetic effects of COX-2. A …